Analysis of combination drug therapy to develop regimens with shortened duration of treatment for tuberculosis.
<h4>Rationale</h4>Tuberculosis remains a worldwide problem, particularly with the advent of multi-drug resistance. Shortening therapy duration for Mycobacterium tuberculosis is a major goal, requiring generation of optimal kill rate and resistance-suppression. Combination therapy is requ...
Guardado en:
Autores principales: | George L Drusano, Michael Neely, Michael Van Guilder, Alan Schumitzky, David Brown, Steven Fikes, Charles Peloquin, Arnold Louie |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1256c6075bff4f35aa29eb4d2784a757 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Preclinical Evaluations To Identify Optimal Linezolid Regimens for Tuberculosis Therapy
por: Ashley N. Brown, et al.
Publicado: (2015) -
Mycobacterium tuberculosis precursor rRNA as a measure of treatment-shortening activity of drugs and regimens
por: Nicholas D. Walter, et al.
Publicado: (2021) -
The Combination of Rifampin plus Moxifloxacin Is Synergistic for Suppression of Resistance but Antagonistic for Cell Kill of <italic toggle="yes">Mycobacterium tuberculosis</italic> as Determined in a Hollow-Fiber Infection Model
por: G. L. Drusano, et al.
Publicado: (2010) -
The effect of stretch–shortening magnitude and muscle–tendon unit length on performance enhancement in a stretch–shortening cycle
por: Martin Groeber, et al.
Publicado: (2021) -
A shortened history of England
por: Macaulay Trevelyan, George
Publicado: (1942)